Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
SMS Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Gross]782.75748.20519.75550.48605.07
Less: Excise/Sevice Tax/Other Levies0.0041.740.0035.4744.26
Revenue From Operations [Net]782.75706.46519.75515.02560.82
Other Operating Revenues0.002.812.304.862.36
Total Operating Revenues782.75709.26522.05519.87563.18
      
Other Income6.224.464.895.203.45
Total Revenue788.97713.72526.94525.07566.63
      
EXPENSES     
Cost Of Materials Consumed501.87425.26299.73387.95313.27
Operating And Direct Expenses0.0073.4457.3155.0439.39
Changes In Inventories Of FG,WIP And Stock-In Trade-64.81-1.0036.08-112.5026.73
Employee Benefit Expenses80.0864.1555.0451.0241.17
Finance Costs18.5423.4621.9218.8811.16
Depreciation And Amortisation Expenses34.3431.5232.1332.1522.28
Other Expenses126.6130.7919.3724.0321.50
Total Expenses696.64647.62521.59456.57475.51
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax92.3466.115.3568.5091.12
      
Profit/Loss Before Tax92.3466.115.3568.5091.12
      
Tax Expenses-Continued Operations     
Current Tax24.9415.000.0615.0016.00
Deferred Tax0.001.781.47-0.0814.11
Tax For Earlier Years0.000.13-0.06-14.300.05
Total Tax Expenses24.9416.911.470.6230.16
Profit/Loss After Tax And Before ExtraOrdinary Items67.4049.203.8867.8860.96
      
Profit/Loss From Continuing Operations67.4049.203.8867.8860.96
      
Profit/Loss For The Period67.4049.203.8867.8860.96
      
Minority Interest0.000.00-10.94-5.660.00
Share Of Profit/Loss Of Associates1.740.630.000.001.56
Consolidated Profit/Loss After MI And Associates69.1449.83-7.0662.2262.53
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)8.165.89-0.837.357.39
Diluted EPS (Rs.)8.165.89-0.837.357.39
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.002.542.542.540.00
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue1.00
  
INCOME 
Revenue From Operations [Gross]782.75
Less: Excise/Sevice Tax/Other Levies0.00
Revenue From Operations [Net]782.75
Other Operating Revenues0.00
Total Operating Revenues782.75
Other Income6.22
Total Revenue788.97
EXPENSES 
Cost Of Materials Consumed501.87
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade-64.81
Employee Benefit Expenses80.08
Finance Costs18.54
Depreciation And Amortisation Expenses34.34
Other Expenses126.61
Total Expenses696.64
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax92.34
Profit/Loss Before Tax92.34
Tax Expenses-Continued Operations 
Current Tax24.94
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses24.94
Profit/Loss After Tax And Before ExtraOrdinary Items67.40
Profit/Loss From Continuing Operations67.40
Profit/Loss For The Period67.40
Minority Interest0.00
Share Of Profit/Loss Of Associates1.74
Consolidated Profit/Loss After MI And Associates69.14
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)8.16
Diluted EPS (Rs.)8.16
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.00